Vanda Pharmaceuticals
VNDA
VNDA
169 hedge funds and large institutions have $319M invested in Vanda Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 49 funds opening new positions, 62 increasing their positions, 38 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
7.3% more ownership
Funds ownership: 70.88% → 78.18% (+7.3%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
14% less capital invested
Capital invested by funds: $369M → $319M (-$50M)
Holders
169
Holding in Top 10
2
Calls
$5.8M
Puts
$1.06M
Top Buyers
| 1 | +$13.5M | |
| 2 | +$7.53M | |
| 3 | +$5.8M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$4.88M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$4.6M |
Top Sellers
| 1 | -$4.74M | |
| 2 | -$3.84M | |
| 3 | -$2.83M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$2.67M |
| 5 |
JF
Jump Financial
Chicago,
Illinois
|
-$2.12M |
